연구물
20건 검색
- 연구출판물 · 학술지 논문JCR Q3Mean cell volume can be an early predictor for the cytogenetic response of chronic myeloid leukemia patients treated with imatinib?
- 연구출판물 · 학술지 논문JCR Q2Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia
Sohn, Sang KyunOh, Suk JoongKim, Byung SooRyoo, Hun Mo정주섭외 25명
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk
Weisel, KatjaSpencer, AndrewLentzsch, SuzanneAvet-Loiseau, HervéMark, Tomer M.신호진외 28명
- 연구출판물 · 학술지 논문JCR Q2Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine
Kim, Dae-YoungLee, Je-HwanLee, Jung-HeeLee, Kyoo-HyungKim, Yoe-Kyeoung신호진외 13명
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors
- 연구출판물 · 학술지 논문Scopus Q3KCI Q4Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea
Ahn, Seo-YeonSon, Sang KyunLee, Gyu HyungKim, InhoCheong, June-Won조수희외 24명
- 연구출판물 · 학술지 논문JCR Q3Scopus Q3The t(11;14)(q13;q32) Trans location as a Poor Prognostic Parameter for Autologous Stem Cell Transplantation in Myeloma Patients With Extramedullary Plasmacytoma
- 연구출판물 · 학술지 논문JCR Q4Scopus Q2Clinical Factors Associated with Response or Survival after Chemotherapy in Patients with Waldenstrom Macroglobulinemia in Korea
Lee, Ho SupKim, KihyunYoon, Dok HyunKim, Jin SeokBang, Soo-Mee신호진외 14명
- 연구출판물 · 학술지 논문JCR Q1Immunoglobulin D multiple myeloma: response to therapy, survival, and prognostic factors in 75 patients
Kim, M. K.Suh, C.Lee, D. H.Min, C. -K.Kim, S. J.신호진외 14명
- 연구출판물 · 학술지 논문JCR Q2Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
- 연구출판물 · 학술지 논문Induction Treatment With Cyclophosphamide, Thalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma: A Phase II Study
- 연구출판물 · 학술지 논문JCR Q2Scopus Q2Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed
Kim, Hye JinYoon, Sung-SooLee, Dong SoonSohn, Sang KyunEom, Hyeon Seok정주섭외 11명
- 연구출판물 · 학술지 논문JCR Q2Scopus Q2Report on outcomes of hypomethylating therapy for analyzing prognostic value of Revised International Prognostic Scoring System for patients with lower-risk myelodysplastic syndromes
- 연구출판물 · 학술지 논문JCR Q2Treatment Outcomes of Pediatric Acute Myeloid Leukemia in the Yeungnam Region: A Multicenter Retrospective Study of the Study Alliance of Yeungnam Pediatric Hematology-Oncology (SAYPH)
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Superior outcomes and high-risk features with carfilzomib, lenalidomide, and dexamethasone combination therapy for patients with relapsed and refractory multiple myeloma: results of the multicenter KMMWP2201 study
- 연구출판물 · 학술지 논문JCR Q2Scopus Q2Real-world outcomes of ponatinib in heavily pretreated patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia
Lee, SeokKim, Hyeoung-JoonCheong, June-Won신호진Kong, Jee Hyun외 21명
- 연구출판물 · 학술지 논문JCR Q2Scopus Q1Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registry
- 연구출판물 · 학술지 논문JCR Q4Scopus Q3Tenofovir Alafenamide Promotes Differentiation and Induces Apoptosis of AML Cells by Inhibiting Telomerase Reverse Transcriptase
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR
Spencer, AndrewLentzsch, SuzanneWeisel, KatjaAvet-Loiseau, HervéMark, Tomer M.신호진외 31명



로그인
홈
Researcher Page
ORCID
ISNI